• ARTES Joins Global Combat against Corona b3cnewswire
    April 27, 2020
    ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, entered development of SARS-CoV-2 vaccine candidates based on its virus-like particle (VLP) based platform technologies METAVAX® and SplitC
PharmaSources Customer Service